3//SEC Filing
OrbiMed Capital GP V LLC 3
Accession 0000947871-20-000736
CIK 0001720580other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 9:37 PM ET
Size
11.7 KB
Accession
0000947871-20-000736
Insider Transaction Report
Form 3
Adicet Bio, Inc.ACET
OrbiMed Israel GP II, L.P.
10% Owner
Holdings
- 0(indirect: See Footnote)
No securities are beneficially owned
OrbiMed Israel GP Ltd.
10% Owner
Holdings
- 0(indirect: See Footnote)
No securities are beneficially owned
Holdings
- 0(indirect: See Footnote)
No securities are beneficially owned
OrbiMed Capital GP V LLC
10% Owner
Holdings
- 0(indirect: See Footnote)
No securities are beneficially owned
OrbiMed Advisors Israel II Ltd
10% Owner
Holdings
- 0(indirect: See Footnote)
No securities are beneficially owned
Footnotes (1)
- [F1]This report is being jointly filed by OrbiMed Capital GP V LLC, OrbiMed Israel BioFund GP Limited, OrbiMed Israel GP Ltd., OrbiMed Israel Partners II, L.P., and OrbiMed Israel GP II, L.P. The Reporting Persons have designated Carl L. Gordon ("Gordon") and Erez Chimovits ("Chimovits") to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, Gordon, or Chimovits is a beneficial owner of the Issuer's securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
Adicet Bio, Inc.
CIK 0001720580
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001615374
Filing Metadata
- Form type
- 3
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 9:37 PM ET
- Size
- 11.7 KB